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Purpose: Despite refinements in surgical techniques for liver resection, evaluation of 
hepatic reserve disparity remains one of the most common problems in liver surgery, 
especially for hepatic malignancies such as hepatocellular carcinoma (HCC). Portal 
venous pressure (PVP) is regarded one of the important factors in selecting treatment 
strategy, although its measurement can be invasive and complex.  
Methods: To establish a formula for calculating PVP preoperatively, intraoperative 
directly measured PVP was used in 177 patients with preoperative factors and liver 
function tests such as age, sex, virus status, platelet count, prothrombin time, albumin, 
total bilirubin, alanine aminotransferase (ALT), Child–Pugh grade, liver damage defined 
by the Liver Cancer Study Group of Japan, indocyanine green retention rate at 15 min 
(ICG-R15), and the aspartate transaminase (AST)-platelet ratio index (APRI).  
Results: After multiple regression analysis, the formula PVP (cmH2O) = EXP[2.606＋
0.01×(ICG-R15)+0.015×APRI] was established from the measured data (r = .495 
(p<0.01)).  
Conclusion: Considering its simplicity of use, we have adopted the formula for predicting 
PVP in determining treatment strategy for HCC and other hepatic malignancies. 
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Outcomes of liver resection for hepatocellular carcinoma (HCC) have improved due to 
better surgical techniques and patient selection [1].We previously reported that 
intraoperative portal venous pressure (PVP) was a good indicator of postoperative 
complications after hepatectomy and that measurement of portal venous pressure is 
useful in selecting the optimal type of resection in cirrhotic patients with HCC [2]. In 
addition, the value of intraoperative PVP was validated even on recurrence of HCC [3]. 
In the BCLC (Barcelona Clinic Liver Cancer) criteria established in 2001, Bruix 
included PVP in selecting a treatment for HCC [4], especially in European facilities. 
However, in the BCLC criteria, hepatic venous pressure gradient (HVPG) was used as 
the indicator of PVP [5, 6], but this measurement is not always applicable to all patients 
because it needs a skillful radiologist and a facility for performing an angiogram [7]. In 
addition, HVPG is a rather invasive technique which is not standardized outside of 
Europe, e.g. Asian countries, such as Japan [8]. 
Recently, various scores have been advocated for  assessing basic liver 
function or hepatic functional reserves over the Child-Pugh score, such as Albumin-
Bilirubin (ALBI) Grade and Albumin-Indocyanine Green Evaluation (ALICE) grade [9-
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11]. They have been reported to be good indicators in selecting therapeutic modalities or 
predicting survival upon treatment for HCC. However, if PVP could be estimated to 
evaluate the timing of treatment of portal hypertension and selecting therapeutic 
modality for HCC in a cirrhotic liver, it would be of great value, especially when the 
BCLC criteria are used. 
During our previous study, we had collected PVP data along with background 
factors of patients [3].In the present study, in an effort to establish a formula to calculate 
PVP preoperatively, directly measured PVP was used, particularly in patients with liver 
diseases. 
 
Patients and methods 
To establish a formula for calculating PVP, previously collected data for PVP were used 
in 177 patients who underwent hepatectomy between 2000 and 2009.  
 
Direct portal venous pressure measurement 
In the 177 subjects, immediately after celiotomy for liver resection, PVP was 
measured directly [3]. Briefly, a catheter was inserted into a jejunal mesenteric vein 
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around 100–120 cm from the Treitz ligament before liver mobilization and resection. 
For HCC surgery, we do not dissect the hepatoduodenal ligament, since LN dissection is 
not needed. Therefore, we did not puncture the portal vein itself directly.  PVP was 
then measured using a water pressure gauge with saline (Fig. 1). The zero points were 
set at the level of the anterior axillary line. Patients with a history of upper abdominal 
surgery and mesenteric membrane adhesions were excluded, because intubation could 
not be done easily after laparotomy. 
 
Preoperative data 
Patient data collected before surgery included age, sex, virus status, platelet count, 
prothrombin time, albumin, total bilirubin, alanine aminotransferase (ALT), Child–Pugh 
grade, liver damage defined by the Liver Cancer Study Group of Japan (LCSGJ), and 
indocyanine green retention rate at 15 minutes (ICG-R15) (12). The degree of liver 
damage, a procedure that was advocated by the LCSGJ as an alternative to the Child–
Pugh score, was defined by preoperative measurements of ascites, serum bilirubin level, 
serum albumin level, indocyanine green retention rate at 15 minutes (ICG R15), and 
prothrombin activity [13].  
Serological presence of hepatitis B antigens was considered evidence for 
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hepatitis B infection. Serologic presence of hepatitis C antibody was considered an 
indicator of hepatitis C infection. Serum levels of alpha-fetoprotein (AFP) and des-
gamma-carboxy prothrombin (DCP) were measured as tumor  markers. Ishak’s hepatitis 
activity score (HAI score: Grading and Staging) were histologically determined. (14) 
Hepatic resections were classified according to the terminology of the Liver 
Cancer Study Group of Japan (12).  
The aspartate transaminase (AST)-platelet ratio index (APRI), which is a well-
established marker for liver fibrosis, was used as indicators for monitoring esophageal 
varices [15]. 
Informed consent was obtained [3], and the study protocol has been approved 
by the institutional committee on human research. 
 
Statistical analysis 
All values are expressed as median and range. Correlation between PVP and clinical 
factors were calculated using Spearman rank-order correlation. Multiple regression 
analysis was performed to establish a formula to calculate PVP preoperatively.  
 
Results 
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The characteristics of the 177 patients with HCC are summarized in Table 1. Almost 90% 
of the patients were in Child-Pugh classification A because they were fair candidates for 
hepatic resection, while the grade of liver damage was worse than Child-Pugh 
classification, probably because of high ICG-R15. Major hepatectomy greater than hemi-
hepatectomy was performed in 30% of the patients. Median APRI (AST/Platelet) was 
0.76 (0.08 - 8.01), while median ICG-R15 was 13.0 % (1-40). 
In the 177 subjects, immediately after celiotomy for liver resection, PVP was 
measured directly.  Although 90% of the patients were classified as Child-Pugh A, 
median direct PVP was 16.5cm H2O (5.5-37.0) and the percentage of PVP greater than 
20cm H2O was 27.1%, reflecting portal hypertension due to liver damage 
Four independent factors, that is, platelet counts, serum levels of albumin, ICG-
R15, and APRI, were extracted and showed a certain extent of correlation with PVP (Fig. 
2). Other factors were not correlated with directly measured PVP.  From the measured 
data, applying multiple regression analysis, PVP (cmH2O) = EXP[2.606＋0.01×(ICG-
R15)+0.015×APRI] was established (r = .495, p<0.01)) as a predictive formula. 
 
Discussion 
As a result, we can advocate the formula of PVP = EXP[2.606 ＋ 0.01×(ICG-
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R15)+0.015×APRI]. Considering its simplicity of use, we adopted the formula for 
predicting PVP in determining treatment strategy for HCC and other hepatic malignancies. 
Portal venous pressure has been found to reflect the degree to which the liver 
parenchyma is damaged [16]. Measuring PVP is useful in determining the final 
indications for surgery also in cirrhotic patients with HCC [2, 12-15]. In a meta-
analysis, morbidity and mortality after hepatectomy were 6.1%, 2.8%, and 41.7%, 
34.7%, respectively [17]. In addition, Berigotti et al reported that the rate of liver failure 
after hepatectomy was much higher in patients with portal hypertension (PHT) than in 
those without PHT [18]. In those studies, some defined PHT as platelet count less than 
100x103 and diameter of the spleen greater than 12cm, while some used HVPG [19, 
20]. They even reported that long-term recurrence-free survival after hepatectomy was 
correlated with PVP. Therefore, it is important to know the PVP based on 
preoperatively measured values with ease [21]. We could make resection smaller if 
estimated PVP is high, or we would be convinced to perform a larger resections if PVP 
is within normal range. For those reasons, we established this formula for predicting 
PVP preoperatively. 
The equation for PVP that we calculated contains ICG retention rate at 15 
minutes and APRI. ICG-R15 has not been considered to reflect PVP directly as we 
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reported previously but rather a comprehensive reflection of liver fibrosis and collateral 
formation in the body [2]. In addition, ICG-R15 has been used as one element of the 
Japanese assessment of liver function instead of the Child-Pugh classification and has 
been called a more objective evaluation of the degree of liver damage [22]. On the other 
hand, APRI consists of AST level and the number of platelets, which has been regarded 
as one of the most important reflections of PHT as the result of hypersplenism. Therefore, 
our equation could be a reasonable one calculated from direct measurement of PVP. In 
the clinical setting, degree of portal hypertension and liver functions such as synthetic 
function and conjugation are somewhat different and dissociated (23-26). That is why our 
formula could be of use clinically.  
There are some limitations in this study. First, although we reported the 
relationship between direct PVP and postoperative complications, the patients in this 
study were a completely different cohort from the previous study [2]. Therefore, we 
should have performed the same analysis with the current cohort. Second, validation of 
similarity between the estimated PVP and the directly measured PVP should be done in 
a prospective manner. Third, the number of calculate PVP was only 177, which ideally 
should have been bigger to obtain a more reliable formula. Finally, relevant factors such 
as spleen size etc. should be investigated in future research. 





Considering its simplicity of use, we adopted this formula for predicting PVP in 
determining treatment strategy for HCC or other hepatic malignancies. The formula 
needs further validation using data from patients of all ethnicities.  
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Fig. 1. Direct measurement of portal venous pressure in patients undergoing hepatectomy 
for hepatocellular carcinoma. A: Jejunal vein at 100-120cm from Treitz ligament was 
cannulated immediately after celiotomy. B: Direct measurement using manometer with 
normal saline at the right atrium level. 
 
Fig. 2. Correlated factors with portal venous pressure (n=177) 
 
                                                      



















      
Ages(years)  65 (20-81) Tumor diameter (cm) 3.5 (0.5-17.0) 
Gender(M:F) 147 : 30 Solitary tumor 130 (73.5%) 
Etiology   Type of hepatectomy  
Hepatitis B  47 (26.5%) Partial and   
Hepatitis C 84 (47.5%) Segmentectomy 117 (66.1%) 
Hepatitis B + C 3 (1.7%) Major hepatectomy 60 (33.9%) 
nonBnonC 43 (24.3%) Vascular invasion 50 (28.2%) 
Platelet (x104/mm3) 15.1 (2.6-47) HAI  
Prothrombin time (%) 89.0 (54-122) Grading 5.0 (1-13) 
Albumin (g/dl) 3.9 (2.6-4.8) Staging 3 (0-4) 
Total bilirubin (mg/dl) 0.75 (0.3-4.8) APRI(AST/Platelet) 0.76 (0.08-8.01) 
AST (IU/L) 38 (12-337) IGG R15(%) 13.0 (1-40) 
ALT (IU/L) 40.5 (7-222) LHL15 0.93 (0.61-0.97) 
AFP (ng/ml) 18.7 (1.2-454,300) Child Pugh classification  
DCP (mAU/ml) 67 (1.2-151,367) Class A 160 (90.4%) 
  Class B 17 (9.6%) 
PVP (cmH2O) 16.5 (5.5-37.0) Liver damage  
PVP >= 20  cmH2O 48 (27.1%) Class A 139 (78.5%) 
PVP < 20  cmH2O 129 (72.9%) Class B 35 (19.7%) 
Fig. 1 Direct measurement of PVP
Jejunal vein at 100-120cm from treiz ligament was 
cannulated immediately after celiotomy
Direct measurement using manometer with normal saline 
at the right atrium level. The zero points were set at the 
level of anterior axillary line.
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